{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:05:59Z","timestamp":1793361959476,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2024 Stability Support for Innovative Capacity Building of Guangdong Provincial Scientific Research Institutions","award":["No. KD022024023"],"award-info":[{"award-number":["No. KD022024023"]}]},{"name":"2024 Stability Support for Innovative Capacity Building of Guangdong Provincial Scientific Research Institutions","award":["No. KD022024023"],"award-info":[{"award-number":["No. KD022024023"]}]},{"name":"2024 Stability Support for Innovative Capacity Building of Guangdong Provincial Scientific Research Institutions","award":["No. KD022024023"],"award-info":[{"award-number":["No. KD022024023"]}]},{"name":"2024 Stability Support for Innovative Capacity Building of Guangdong Provincial Scientific Research Institutions","award":["No. KD022024023"],"award-info":[{"award-number":["No. KD022024023"]}]},{"name":"2024 Stability Support for Innovative Capacity Building of Guangdong Provincial Scientific Research Institutions","award":["No. KD022024023"],"award-info":[{"award-number":["No. KD022024023"]}]},{"name":"2024 Stability Support for Innovative Capacity Building of Guangdong Provincial Scientific Research Institutions","award":["No. KD022024023"],"award-info":[{"award-number":["No. KD022024023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-04141-6","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T16:46:23Z","timestamp":1777049183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SGLT-2 inhibitor\u2013associated significant hypernatremia and euglycemic diabetic ketoacidosis after cardiac surgery: a case series"],"prefix":"10.1186","volume":"21","author":[{"given":"En-ze","family":"Bian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-wan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-kun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-zhong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-zheng","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"9786","key":"4141_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","volume":"378","author":"AA Tahrani","year":"2011","unstructured":"Tahrani AA, Bailey CJ, Del Prato S, Barnett AH. Management of type 2 diabetes: new and future developments in treatment. Lancet. 2011;378(9786):182\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(11)60207-9.","journal-title":"Lancet"},{"issue":"10166","key":"4141_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","volume":"393","author":"TA Zelniker","year":"2019","unstructured":"Zelniker TA, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2019;393(10166):31\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(18)32590-X.","journal-title":"Lancet"},{"issue":"10354","key":"4141_CR3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","volume":"400","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, et al. SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. Lancet. 2022;400(10354):757\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(22)01429-5.","journal-title":"Lancet"},{"issue":"10","key":"4141_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","volume":"134","author":"HJL Heerspink","year":"2016","unstructured":"Heerspink HJL, Perkins BA, Fitchett DH, Husain M, Cherney DZI. Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications. Circulation. 2016;134(10):752\u201372. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.021887.","journal-title":"Circulation"},{"key":"4141_CR5","doi-asserted-by":"publisher","first-page":"1482918","DOI":"10.3389\/fcvm.2025.1482918","volume":"12","author":"Q Feng","year":"2025","unstructured":"Feng Q, Wu M, Mai Z. Emerging horizons: clinical applications and multifaceted benefits of SGLT-2 inhibitors beyond diabetes. Front Cardiovasc Med. 2025;12:1482918. https:\/\/doi.org\/10.3389\/fcvm.2025.1482918.","journal-title":"Front Cardiovasc Med"},{"issue":"36","key":"4141_CR6","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368.","journal-title":"Eur Heart J"},{"key":"4141_CR7","doi-asserted-by":"publisher","unstructured":"Kaur A, Winters SJ. Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin, Endocrinol. Diabetes Metab. Case Rep.,2015,2015. https:\/\/doi.org\/10.1530\/EDM-15-0042","DOI":"10.1530\/EDM-15-0042"},{"key":"4141_CR8","doi-asserted-by":"publisher","unstructured":"Lee IH, Ahn DJ. Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: a case report, Medicine (Baltimore),99,21, p. e20228, May 2020, https:\/\/doi.org\/10.1097\/MD.0000000000020228","DOI":"10.1097\/MD.0000000000020228"},{"key":"4141_CR9","doi-asserted-by":"publisher","unstructured":"Gelbenegger G, Buchtele N, Schoergenhofer C, Roeggla M, Schwameis M. Severe hypernatraemic dehydration and unconsciousness in a care-dependent inpatient treated with empagliflozin, Drug Saf. - Case Rep.,4,1, p. 17,2017, https:\/\/doi.org\/10.1007\/s40800-017-0058-8","DOI":"10.1007\/s40800-017-0058-8"},{"key":"4141_CR10","doi-asserted-by":"publisher","unstructured":"Sugiyama J et al. Dapagliflozin induced hypernatremia via osmotic diuresis: a case report, CEN Case Rep.,13,1,9\u201313,2023. https:\/\/doi.org\/10.1007\/s13730-023-00790-x","DOI":"10.1007\/s13730-023-00790-x"},{"issue":"2","key":"4141_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00125-016-4157-3","volume":"60","author":"V Vallon","year":"2017","unstructured":"Vallon V, Thomson SC. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition. Diabetologia. 2017;60(2):215\u201325. https:\/\/doi.org\/10.1007\/s00125-016-4157-3.","journal-title":"Diabetologia"},{"key":"4141_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jcjd.2022.06.007","volume":"46","author":"A Chaudhry","year":"2022","unstructured":"Chaudhry A, Roels C, Lee J. Sodium\u2013glucose cotransporter-2 inhibitor\u2013associated euglycemic diabetic ketoacidosis: lessons from a case series of 4 patients undergoing coronary artery bypass grafting surgery. Can J Diabetes. 2022;46:8,843\u201350. https:\/\/doi.org\/10.1016\/j.jcjd.2022.06.007.","journal-title":"Can J Diabetes"},{"key":"4141_CR13","unstructured":"Hwang SM, Abcejo AS, Jacob AK, Raiten JM, Mundi MS. Editorial: euglycemic ketoacidosis concerns in perioperative use of SGLT2 inhibitors: Re-examining current recommendations."},{"issue":"9","key":"4141_CR14","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2337\/dc15-0843","volume":"38","author":"AL Peters","year":"2015","unstructured":"Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium\u2013glucose cotransporter 2 inhibition. Diabetes Care. 2015;38(9):1687\u201393. https:\/\/doi.org\/10.2337\/dc15-0843.","journal-title":"Diabetes Care"},{"issue":"9","key":"4141_CR15","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.2337\/dc15-1380","volume":"38","author":"J Rosenstock","year":"2015","unstructured":"Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care. 2015;38(9):1638\u201342. https:\/\/doi.org\/10.2337\/dc15-1380.","journal-title":"Diabetes Care"},{"key":"4141_CR16","doi-asserted-by":"publisher","unstructured":"Barski L, Eshkoli T, Brandstaetter E, Jotkowitz A. Euglycemic diabetic ketoacidosis. Eur J Intern Med,63,9\u201314, May 2019, https:\/\/doi.org\/10.1016\/j.ejim.2019.03.014","DOI":"10.1016\/j.ejim.2019.03.014"},{"issue":"7","key":"4141_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11892-017-0874-3","volume":"17","author":"JA Levine","year":"2017","unstructured":"Levine JA, Karam SL, Aleppo G. SGLT2-I in the hospital setting: diabetic ketoacidosis and other benefits and concerns. Curr Diab Rep. 2017;17(7):54. https:\/\/doi.org\/10.1007\/s11892-017-0874-3.","journal-title":"Curr Diab Rep"},{"issue":"8","key":"4141_CR18","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1210\/jc.2015-1884","volume":"100","author":"SI Taylor","year":"2015","unstructured":"Taylor SI, Blau JE, Rother KI. SGLT2 inhibitors may predispose to ketoacidosis. J Clin Endocrinol Metab. 2015;100(8):2849\u201352. https:\/\/doi.org\/10.1210\/jc.2015-1884.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4141_CR19","doi-asserted-by":"publisher","first-page":"pezae355","DOI":"10.1093\/ejcts\/ezae355","volume":"67","author":"EC Hansson","year":"2024","unstructured":"Hansson EC, et al. 2024 EACTS guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg. 2024;67(1):pezae355. https:\/\/doi.org\/10.1093\/ejcts\/ezae355.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"4141_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/00325481.2016.1147322","volume":"128","author":"G Liamis","year":"2016","unstructured":"Liamis G, Filippatos TD, Elisaf MS. Evaluation and treatment of hypernatremia: a practical guide for physicians. Postgrad Med. 2016;128(3):299\u2013306. https:\/\/doi.org\/10.1080\/00325481.2016.1147322.","journal-title":"Postgrad Med"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04141-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04141-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04141-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:17:57Z","timestamp":1781129877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04141-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4141"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04141-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8386747\/v1","asserted-by":"object"}]},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the subject for the publication of this study and any accompanying, in accordance with the regulations of the local ethics committee (KY2025-1001-01, Guangdong Provincial People\u2019s Hospital).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patient consented for publication in research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"379"}}